Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
102.00    0.00 (0.00%)
Bid:
0.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £298.07m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

Trading Statement

24 Jan 2022 07:00

RNS Number : 2998Z
Big Technologies PLC
24 January 2022
 

24 January 2022

 

Big Technologies plc

("Big Technologies" or the "Company" and the "Group") 

Trading Update

 

Big Technologies plc, the UK-based remote people monitoring technology company, issues the following trading update ahead of the announcement scheduled for 24th March 2022 of its full year results for the year ended 31st December 2021.

 

The Group continued to deliver a robust performance throughout 2021 and has continued to win new customers which underpins our revenue forecast for 2022. As a result, revenue for the year ended 31st December 2021 is expected to be at least £36.5 million (2020: £29.6 million) and adjusted EBITDA is expected to be slightly ahead of current market expectations1 of c.£20.2 million (2020: £15.7 million).

 

Net cash as at 31st December 2021 increased to £48 million which provides significant financial flexibility to invest in our operations and technology.

 

As we look forward to 2022 the Group expects to deliver year on year revenue growth at a similar growth rate to that experienced in 2021 and a further increase in the adjusted EBITDA margin as we continue to penetrate new geographic markets and scale-up our business activities.

 

1: by reference to company calculated analyst consensus

 

Sara Murray OBE, Chief Executive Officer commented:

 

"Big Technologies expects to deliver a strong performance for 2021 and beyond. Our business model is one of long term partnership with our customers and has proven to be extremely resilient. Following our successful IPO in July 2021, we have the financial resources to continue to increase our investment in our market-leading technology solutions and grow our footprint both organically and through acquisition. We remain confident about our prospects for the coming year and beyond to continue to develop our company and our innovative technologies."

 

 

 

 

 

For further information please contact:

 

Big Technologies

+44 (0) 19 2360 1910

Sara Murray (Chief Executive Officer)

Daren Morris (Chief Financial Officer)

 

 

 

Zeus Capital (Nominated Adviser and Sole Broker)

+44 (0) 20 3829 5000

Jamie Peel (Corporate Finance)Dan Bate (Corporate Finance)

Benjamin Robertson (Equity Capital Markets)

 

 

 

 

 

About Big Technologies

Big Technologies is the parent company of Buddi, which was founded in 2005 by its current CEO, Sara Murray, following an initial idea to create a GPS device small enough for a child to carry. Today, Big Technologies is a proven supplier of innovative and high-quality products and services to the remote personal monitoring industry. Big Technologies provides products and services under a number of brand and trading names, with 'Buddi' being the most well-known and being used in respect of activities within the core criminal justice market. Big Technologies (under the buddi brand) has created a leading, integrated technology platform (including both hardware and software solutions) for remote monitoring of individuals, providing state-of-the-art Electronic Monitoring (EM) solutions on a SaaS-like, subscription basis.

 

Electronic Monitoring in the criminal justice sector involves utilising location technologies to remotely monitor and manage people at all stages of the criminal justice system. The Company's focus on the Criminal Justice market in the immediate term has been demand-driven, with significant opportunities created by a combination of favourable market tailwinds as electronic location devices are increasingly recognised as alternatives to imprisonment, and superior technological capability enabling the Company to meet this demand effectively.

 

Big Technologies' criminal justice solution has been iteratively developed over a 10-year period, utilising the knowledge of an experienced management team listening to customers. The solution consists of a proprietary software platform with modular monitoring hardware, capable of being adapted to multiple applications. The Company's criminal justice solution is principally focussed around the "Buddi Smart Tag", an electronic monitoring hardware device, and "Buddi Eagle", the in-house developed, cloud-based monitoring software. Collectively, the hardware and the intelligent tools integrated into Big Technologies' software enable real-time tracking of monitored individuals with high levels of accuracy and reliability. Buddi evidences a substantial reduction in false alerts when compared to competitor systems, which combined with the reduction in subsequent investigations can result in substantial cost savings for customers.

 

In addition to the high levels of accuracy, the Buddi Smart Tag has several key advantages over its competitors' devices. The tag is lighter, smaller, has longer battery life and offers a simple, contact free and shorter installation process, providing substantial staff cost savings for customers. This superior product design, coupled with the intelligent monitoring software, typically comes at a small price premium to competitor devices. However, the overall effectiveness and reliability of the solution, combined with the substantial cost savings delivered as a result of reduced monitoring costs, have helped Big Technologies deliver strong revenue growth from both existing and new customers. The Company leases its devices and software solutions to customers typically based on daily or monthly rates

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGZMKFZGZZM
Date   Source Headline
13th Jun 20224:41 pmRNSSecond Price Monitoring Extn
13th Jun 20224:36 pmRNSPrice Monitoring Extension
10th Jun 20224:41 pmRNSSecond Price Monitoring Extn
10th Jun 20224:35 pmRNSPrice Monitoring Extension
31st May 20227:00 amRNSDirector/PDMR Shareholding
27th May 202212:13 pmRNSResult of AGM
27th May 20227:00 amRNSAGM Statement
12th May 20227:00 amRNSDirector/PDMR Shareholding
27th Apr 20227:00 amRNSIncrease in share capital
22nd Apr 20227:00 amRNS2021 Annual Report and Notice of AGM
25th Mar 20222:57 pmRNSDirector/PDMR Shareholding
25th Mar 20222:51 pmRNSDirector/PDMR Shareholding
24th Mar 202210:00 amRNSIncrease in share capital
24th Mar 20227:00 amRNS2021 Preliminary audited results
8th Feb 20224:40 pmRNSSecond Price Monitoring Extn
8th Feb 20224:35 pmRNSPrice Monitoring Extension
28th Jan 20227:00 amRNSDirectorate Change
24th Jan 20227:00 amRNSTrading Statement
18th Jan 20227:00 amRNSIncrease in share capital
5th Jan 202210:14 amRNSDirector/PDMR Shareholding
10th Dec 202111:13 amRNSIncrease in share capital
30th Nov 20214:36 pmRNSPrice Monitoring Extension
18th Nov 20218:02 amRNSContract
4th Nov 20219:03 amRNSHolding(s) in Company
15th Oct 20212:28 pmRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSIncrease in share capital
23rd Sep 20217:00 amRNSHalf-year Report
13th Sep 20217:00 amRNSPreferred Bidder
28th Jul 20217:00 amRNSAdmission to AIM and first day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.